Ciro Franzese (@cirofranzese1) 's Twitter Profile
Ciro Franzese

@cirofranzese1

Radiation oncologist, Associate Professor at Humanitas University, Milan, Italy. Genitourinary cancer, head-neck cancer, liver primary and mets. Dog lover.

ID: 1065185656085929984

calendar_today21-11-2018 10:10:25

347 Tweet

1,1K Followers

657 Following

ISRSy (@isrsy) 's Twitter Profile Photo

We are excited to announce another ISRS guideline was published in Practical Radiation Oncology (PRO) in October! "Stereotactic Body Radiotherapy for liver metastases: Systematic review and meta-analysis with International Stereotactic Radiosurgery Society (ISRS) Practice

ESTRO (@estro_rt) 's Twitter Profile Photo

Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial, published in JAMA Oncology. 👉 Read it before your patients: bit.ly/4hubdoq

Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial, published in <a href="/JAMAOnc/">JAMA Oncology</a>.
👉 Read it before your patients: bit.ly/4hubdoq
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

"Oligo"-no more! 🇨🇦ARREST phase I out now IJROBP - The Red Journal - Sue Yom ➡️SABR to median=16 "poly"metastases in patients who had already exhausted multiple lines of systemic therapy ➡️4x dose levels (up to 6Gyx5). ➡️No safety signals, QoL maintained. shorturl.at/gStwt Congrats! 👏👏

"Oligo"-no more! 🇨🇦ARREST phase I out now <a href="/IJROBP/">IJROBP - The Red Journal</a> - <a href="/sueyom/">Sue Yom</a> 
➡️SABR to median=16 "poly"metastases in patients  who had already exhausted multiple lines of systemic therapy
➡️4x dose levels (up to 6Gyx5). 
➡️No safety signals, QoL maintained. shorturl.at/gStwt Congrats! 👏👏
Pierre Blanchard, MD (@pblanchardmd) 's Twitter Profile Photo

PEACE-1 RT is now published online at The Lancet Some differences with STAMPEDE Key messages: RT to prostate in M1 #prostatecancer 1. improves rPFS but not OS in low volume 2. improves CRPC-FS & reduces serious GU SAE irrespective of volume Full text: thelancet.com/journals/lance…

PEACE-1 RT is now published online at <a href="/TheLancet/">The Lancet</a> 

Some differences with STAMPEDE

Key messages: RT to prostate in M1 #prostatecancer
1. improves rPFS but not OS in low volume
2. improves CRPC-FS &amp; reduces serious GU SAE irrespective of volume

Full text: thelancet.com/journals/lance…
Eur Urol Focus (@eururolfocus) 's Twitter Profile Photo

Radical cystectomy (RC) and trimodality therapy (TMT) yield comparable outcomes in muscle-invasive bladder cancer (MIBC)? ✨ 74.4% complete response with TMT. 🔄 23.1% recurrence rate in TMT-treated patients. ⚠️ 11.4% grade ≥3 toxicity for TMT. Does this change your practice?

Ciro Franzese (@cirofranzese1) 's Twitter Profile Photo

It's that time of the year when we need to slow down and return to our roots, to our family and loved ones. And that's exactly what we're doing. We wish everyone a Merry Christmas and a wonderful 2025! (Yes, we're stuck in traffic!!!)

It's that time of the year when we need to slow down and return to our roots, to our family and loved ones. And that's exactly what we're doing. We wish everyone a Merry Christmas and a wonderful 2025! (Yes, we're stuck in traffic!!!)
European Urology (@euplatinum) 's Twitter Profile Photo

SPOTLIGHT: Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial by Nicholas van As Read the full article here: buff.ly/3OSVsu6 #UroSoMe #MedTwitter #eururol #EditorsChoice #spotlight

Gustavo (@gusviani) 's Twitter Profile Photo

🚨 The 2024 FROGG Guidelines for Post-Prostatectomy Radiation Therapy (PPRT) are here, bringing groundbreaking updates backed the by the latest evidence❗️OncoAlert 🧵1/7

🚨 The 2024 FROGG Guidelines for Post-Prostatectomy Radiation Therapy (PPRT) are here, bringing groundbreaking updates backed the by the latest evidence❗️<a href="/OncoAlert/">OncoAlert</a> 🧵1/7
The Lancet Oncology (@thelancetoncol) 's Twitter Profile Photo

Very sad day for Americans and the world, a calamity: Trump orders US to leave World Health Organization bbc.com/news/articles/…

Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

A 33 min overview of GI rad onc! I made this video for an oral boards review course, sharing here. It’s just 5 slides (below) & me talking the whole time, so you can just listen. Hope it’s helpful! Link next post, and short 🧵.

A 33 min overview of GI rad onc!

I made this video for an oral boards review course, sharing here.

It’s just 5 slides (below) &amp; me talking the whole time, so you can just listen.

Hope it’s helpful! Link next post, and short 🧵.
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

📢🚨 Hot off the press The Lancet Oncology for #kidneycancer! shorturl.at/kAGVd. SABR vs thermal ablation; - Despite ⏫age, ⏬worse GFR, and ⏫tumours for SABR - SABR ⬆️effective than TA (at 1, 2 and 5 yrs) - esp for RCC >4cm - same renal decline (p=0.75) - similar F/U #radonc

📢🚨 Hot off the press <a href="/TheLancetOncol/">The Lancet Oncology</a> for #kidneycancer! shorturl.at/kAGVd. SABR vs thermal ablation;
- Despite ⏫age, ⏬worse GFR, and ⏫tumours for SABR
- SABR ⬆️effective than TA (at 1, 2 and 5 yrs)
- esp for RCC &gt;4cm
- same renal decline (p=0.75)
- similar F/U #radonc
Ciro Franzese (@cirofranzese1) 's Twitter Profile Photo

Joining forces against kidney cancer! Published a new international multicenter study on SBRT for renal cell carcinoma SBRT is a valuable option with: ✅ 96% local control at 5 years ✅ Good preservation of renal function ✅ Acceptable toxicity profile with only 1% of G ≥3

Joining forces against kidney cancer!

Published a new international multicenter study on SBRT for renal cell carcinoma

SBRT is a valuable option with:  
✅ 96% local control at 5 years
✅ Good preservation of renal function
✅ Acceptable toxicity profile with only 1% of G ≥3
Filippo Alongi (@alongi_filippo) 's Twitter Profile Photo

-This large series of primary RCC treated with SBRT demonstrates excellent LC and renal function preservation. -SBRT is an alternative treatment for inoperable patients. 💪 Shankar Siva David Pasquier Ciro Franzese Luca Nicosia MD marta scorsetti 👉sciencedirect.com/science/articl…

-This large series of primary RCC treated with SBRT demonstrates excellent LC and renal function preservation. 
-SBRT is an alternative treatment for inoperable patients. 💪
<a href="/_ShankarSiva/">Shankar Siva</a> <a href="/David__Pasquier/">David Pasquier</a> <a href="/CiroFranzese1/">Ciro Franzese</a> <a href="/NicosiaMd/">Luca Nicosia MD</a> <a href="/MartaScorsetti/">marta scorsetti</a> 

👉sciencedirect.com/science/articl…
Oncology Brothers (@oncbrothers) 's Twitter Profile Photo

#GU25 highlights #CommunityOnc: 1. Radical ✂️ vs. XRT high risk PCa 2. #TALAPRO2: PARPi in M1 CRPC 3. #EnzaP: ARPi + LuPSMA in M1 CRPC 4. #NIAGARA update: Resectable MIBC 5. #EV302 update: Metastatic #BladderCancer 6. #CM9ER update: 1L mRCC #OncTwitter #gism ASCO 1/7

#GU25 highlights #CommunityOnc:

1. Radical ✂️ vs. XRT high risk PCa

2. #TALAPRO2: PARPi in M1 CRPC

3. #EnzaP: ARPi + LuPSMA in M1 CRPC

4. #NIAGARA update: Resectable MIBC

5. #EV302 update: Metastatic #BladderCancer 

6. #CM9ER update: 1L mRCC

#OncTwitter #gism <a href="/ASCO/">ASCO</a> 

1/7
URONCOR (@uroncor) 's Twitter Profile Photo

Fantastic roundtable on renal & prostate #SBRT with Ciro Franzese 🇮🇹 & MoShelan 🇨🇭 ! ✅ Growing evidence for renal SBRT with excellent local control ✅ Comparisons of SBRT regimens even in 1-2 sessions! Many thanks for your participation!

Fantastic roundtable on renal &amp; prostate #SBRT with <a href="/CiroFranzese1/">Ciro Franzese</a> 🇮🇹 &amp; <a href="/DrMedo58935306/">MoShelan</a> 🇨🇭 !

✅ Growing evidence for renal SBRT with excellent local control 

✅ Comparisons of SBRT regimens  even in 1-2 sessions!

Many thanks for your participation!
Piet Ost (@piet_ost) 's Twitter Profile Photo

SBRT + 💊 in oligomets: 🧍‍♂️2294 pts | 🫁, breast, prostate, colorectal ⚠️Grade 3+ AEs: 1.5% ✅ SBRT Safe with systemic tx! #SBRT #OligoCare #ESTRO25 EORTC ESTRO Ciro Franzese

SBRT + 💊 in oligomets:
🧍‍♂️2294 pts | 🫁, breast, prostate, colorectal
⚠️Grade 3+ AEs: 1.5%
✅ SBRT Safe with systemic tx!
#SBRT #OligoCare #ESTRO25 <a href="/EORTC/">EORTC</a> <a href="/ESTRO_RT/">ESTRO</a> <a href="/CiroFranzese1/">Ciro Franzese</a>
Stefano Arcangeli (@star_mcm74) 's Twitter Profile Photo

🎩🎩 off to 🇮🇹 Giulio Francolini Giulia Marvaso and Ciro Franzese for handling the GU sessions #ESTRO25 so well, either as chairs or speakers ⚡️so inspiring for the younger colleagues 🤩 #ProstateCancer #radonc ESTRO

Sarah Scagliarini, MD (@sscagliarini_) 's Twitter Profile Photo

#UroOncoJourney2025 🇮🇹 The multidisciplinary debate on #RCC is always heated 🔥 even more so if the best ( Camillo Porta,Ciro Franzese, Andrea Minervini) take the field, expertly arbitrated by Roberto Iacovelli. However, the goal can only be achieved together!! 🥅 UroFocus ANTURE - Associazione Nazionale Tumore del Rene

#UroOncoJourney2025  🇮🇹
The multidisciplinary debate on #RCC is always heated 🔥 even more so if the best ( <a href="/CPRT65/">Camillo Porta</a>,<a href="/CiroFranzese1/">Ciro Franzese</a>, Andrea Minervini) take the field, expertly arbitrated by <a href="/DrIacovelli/">Roberto Iacovelli</a>. However, the goal can only be achieved together!! 🥅 <a href="/urofocus/">UroFocus</a> <a href="/AntureIT/">ANTURE - Associazione Nazionale Tumore del Rene</a>